Christopher Thomas Giordano

Insider Reports History

Location
C/O Tenax Therapeutics, Inc., One Copley Parkway, Suite 490, Morrisville, NC
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Thomas Giordano:

Stock Role Class Num Shares Value Price $ Report Date Ownership
TENAX THERAPEUTICS, INC. CEO, Director Stock Option (right to buy) 1.4M $10.1M $7.23 Nov 18, 2025 Direct
TENAX THERAPEUTICS, INC. CEO, Director Common Stock 2.61K $19.8K $7.59 Nov 20, 2025 Direct

Insider Reports Filed by Christopher Thomas Giordano

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TENX TENAX THERAPEUTICS, INC. Nov 18, 2025 3 $20K 4 Nov 20, 2025 CEO, Director
TENX TENAX THERAPEUTICS, INC. May 16, 2025 1 $0 4 May 20, 2025 CEO, Director
TENX TENAX THERAPEUTICS, INC. Dec 10, 2024 1 $0 4 Dec 12, 2024 CEO, Director
TENX TENAX THERAPEUTICS, INC. May 17, 2024 1 $0 4 May 21, 2024 CEO, Director
TENX TENAX THERAPEUTICS, INC. Jun 9, 2022 1 $0 4 Jun 10, 2022 CEO, Director
TENX TENAX THERAPEUTICS, INC. Jul 14, 2021 0 $0 3 Jul 15, 2021 CEO, Director